3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Stevens-Johnson Syndrome: new trials by email Literature Review of Stevens-Johnson Syndrome trials Research Report on Stevens-Johnson Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NATIENS: Optimal Management and Mechanisms of SJS/TEN Harmonized supportive care, Etanercept 50 mg sc day 1 and day 4 - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses | Phase 3 | Completed | Vanderbilt University Medical Center | 2 | 2023-03-21 | 2025-12-17 |
| Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. Intravenous immunoglobulin - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis | Phase 3 | Completed | Nihon Pharmaceutical Co., Ltd | 10 | 2012-10-01 | 2014-07-02 |
| Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation Cultivated conjunctival transplantation - Pterygium, Ocular Surface Disease | Phase 3 | Completed | Singapore National Eye Centre | 80 | 2001-10-01 | 2010-01-13 |
Drug-Related Side Effects and Adverse Reactions (1) · Pterygium (1)
Chemically-Induced Disorders (3) · Dermatitis (3) · Drug Eruptions (3) · Drug Hypersensitivity (3) · Erythema (3) · Erythema Multiforme (3) · Hypersensitivity (3) · Hypersensitivity, Delayed (3) · Immune System Diseases (3) · Mouth Diseases (3) · Skin Diseases (3) · Skin Diseases, Vesiculobullous (3) · Skin and Connective Tissue Diseases (3) · Stomatitis (3) · Stomatognathic Diseases (3)
Etanercept (1) · Immunoglobulins, Intravenous (1)
Nihon Pharmaceutical Co., Ltd (1) · Singapore National Eye Centre (1) · Vanderbilt University Medical Center (1)
Japan (1) · Singapore (1) · United States (1)
Donald T Tan, FRCS (1) · Elizabeth J Phillips, MD (1) · Leonard P Ang, FRCS (1)